drugset / Trial / NCT01105117
Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, non-randomized extension to study AC-066A401. The study will assess safety and tolerability of ACT-385781A and Flolan (epoprostenol sodium) while providing a means for continuing treatment after ending participation in study AC-0066A401.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-07
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | epoprostenol | Other / unclassified | — | — |